Cargando…

Prevalence, predictors, and management for balloon uncrossable or undilatable lesions in patients undergoing percutaneous coronary intervention with in-stent restenosis chronic total occlusion

BACKGROUND: Percutaneous coronary intervention for in-stent restenosis (ISR) chronic total occlusion (CTO) has been a great challenge. There are occasions when the balloon is uncrossable or undilatable (BUs) even though the guidewire has passed, leading to failure of the procedure. Few studies have...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Yong, Hou, Ai-jie, Luan, Bo, Zhang, Xiao-jiao, Li, Zhao-yu, Pei, Xiao-yang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Cardiovascular Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10265741/ https://www.ncbi.nlm.nih.gov/pubmed/37324628 http://dx.doi.org/10.3389/fcvm.2023.1095960

Ejemplares similares

Shockwave intracoronary lithotripsy for the treatment of calcium-mediated undilatable in-stent restenosis
por: Kuzemczak, Michał, et al.
Publicado: (2022)

Severely Circumferentially Calcified Neointima as a New Cause of Undilatable In-Stent Restenosis
por: Kashiwagi, Manabu, et al.
Publicado: (2018)

Usefulness of excimer laser atherectomy for balloon uncrossable lesion in chronic total occlusion
por: Sueta, Daisuke, et al.
Publicado: (2015)

Angiographic Features and Clinical Outcomes of Balloon Uncrossable Lesions during Chronic Total Occlusion Percutaneous Coronary Intervention
por: Karacsonyi, Judit, et al.
Publicado: (2023)

Predictors of restenosis following percutaneous coronary stent implantation: The role of trimetazidine therapy
por: Csató, Gábor, et al.
Publicado: (2022)

Efficacy and safety of Tornus catheter in percutaneous coronary intervention of hard or balloon-uncrossable chronic total occlusion
por: Mohandes, Mohsen, et al.
Publicado: (2016)

Shockwave intravascular lithotripsy as a novel strategy for balloon undilatable heavily calcified chronic total occlusion lesions
por: Rola, Piotr, et al.
Publicado: (2023)

Efficacy and safety of balloon-assisted microdissection with Sapphire® II 1.0-mm balloon in balloon-uncrossable chronic total occlusion lesions
por: Ye, Yicong, et al.
Publicado: (2020)

Intracoronary Lithotripsy: A New Solution for Undilatable In-Stent Chronic Total Occlusions
por: Karacsonyi, Judit, et al.
Publicado: (2021)

Utility of coronary orbital atherectomy with guide‐extension system for distally located undilatable in‐stent restenosis: A case report
por: Yamamoto, Hiroyuki, et al.
Publicado: (2022)

Interventional Management of “Balloon-Uncrossable” Coronary Chronic Total Occlusion: Is There Any Way Out?
por: Dash, Debabrata
Publicado: (2018)

Intravascular Ultrasound and Angiographic Predictors of In-Stent Restenosis of Chronic Total Occlusion Lesions
por: Kang, Jeehoon, et al.
Publicado: (2015)

Local drug-delivery balloon for proliferative occlusive in-stent restenosis after drug-eluting stent
por: Rigatelli, Gianluca, et al.
Publicado: (2011)

Undilatable Stent Neoatherosclerosis Treated with Ad Hoc Rotational Atherectomy
por: Koutouzis, Michael, et al.
Publicado: (2017)

New predictors of in-stent restenosis in patients with diabetes mellitus undergoing percutaneous coronary intervention with drug-eluting stent
por: Wang, Jian-Long, et al.
Publicado: (2018)

Serum glycated albumin is associated with in-stent restenosis in patients with acute coronary syndrome after percutaneous coronary intervention with drug-eluting stents: An observational study
por: Lin, Xiao Long, et al.
Publicado: (2022)

Comparison of new-generation drug-eluting stents versus drug-coated balloon for in-stent restenosis: a meta-analysis of randomised controlled trials
por: Cai, Jin-Zan, et al.
Publicado: (2018)

Long-term clinical outcomes for patients with uncrossable patent foramen ovale
por: Shin, Yonghoon, et al.
Publicado: (2023)

Smart solution for hard times: successful lithoplasty of an undilatable lesion
por: Vainer, J., et al.
Publicado: (2019)

The number of stents was an independent risk of stent restenosis in patients undergoing percutaneous coronary intervention
por: Tang, Long, et al.
Publicado: (2019)

Factors Affecting In-stent Restenosis in Patients Undergoing Percutaneous Coronary Angioplasty
por: Sajadian, Mostafa, et al.
Publicado: (2018)

Drug-Coated Balloon for the Treatment of Femoropopliteal Tosaka Class III In-stent Restenosis Lesions
por: Zhang, Bihui, et al.
Publicado: (2021)

The power of gold: a tip for an uncrossable ostial lesion
por: Ściborski, Krzysztof K., et al.
Publicado: (2021)

What Is the Future of Drug-Coated Balloons for In-Stent Restenosis?
por: Chen, Yun-Dai, et al.
Publicado: (2022)

Drug-coated balloons for the treatment of stent edge restenosis
por: Nagasaka, Takashi, et al.
Publicado: (2023)

Percutaneous treatment of left main chronic total occlusion with paclitaxel-coated balloon
por: Kim, Mijin, et al.
Publicado: (2021)

In vivo angioscopy evaluation of drug-eluting stent occlusion treated with drug-coated balloon
por: Horikoshi, Takeo, et al.
Publicado: (2023)

Drug-coated balloon therapy is more effective in treating late drug-eluting stent in-stent restenosis than the early occurring one—a systematic review and meta-analysis
por: Kulyassa, Péter, et al.
Publicado: (2023)

Neutrophil-to-Lymphocyte Ratio Predicts Restenosis After Drug-Coated Balloon Therapy for Femoropopliteal Artery Lesions: A Retrospective Study
por: Wang, Zhihong, et al.
Publicado: (2022)

Successful bailout of stent graft stuck in stent occlusion lesion
por: Kato, Tamon, et al.
Publicado: (2020)

Technical success, clinical efficacy, and insight into the causes of restenosis after the percutaneous coronary intervention of de novo coronary artery lesions using a paclitaxel-coated balloon with citrate ester excipient
por: Tervo, Jerry, et al.
Publicado: (2022)

Heavy Coronary Calcium Mimicking In-Stent Restenosis
por: Park, Jeong-Hwan, et al.
Publicado: (2011)

Long-term clinical effectiveness of a drug-coated balloon for in-stent restenosis in Femoropopliteal lesions
por: Horie, Kazunori, et al.
Publicado: (2021)

Analysis of the incidence and influencing factors associated with binary restenosis of target lesions after drug-coated balloon angioplasty for patients with in-stent restenosis
por: Xue, Weihao, et al.
Publicado: (2022)

Comparison of Drug-Coated Balloon Angioplasty vs. Drug-Eluting Stent Implantation for Drug-Eluting Stent Restenosis in the Routine Clinical Practice: A Meta-Analysis of Randomized Controlled Trials
por: Zhu, Yong, et al.
Publicado: (2021)

Intravascular imaging in coronary stent restenosis: Prevention, characterization, and management
por: Abouelnour, Amr, et al.
Publicado: (2022)

In stent restenosis after percutaneous coronary intervention
por: Eyüboğlu, Mehmet
Publicado: (2016)

Drug-coated balloon in superficial femoral artery in-stent restenosis
por: Gerardi, Donato, et al.
Publicado: (2018)

Enabling Angioplasty‐Ready “Smart” Stents to Detect In‐Stent Restenosis and Occlusion
por: Chen, Xing, et al.
Publicado: (2018)

Percutaneous Coronary Intervention vs. Coronary Artery Bypass Grafting for Treating In-Stent Restenosis in Unprotected-Left Main: LM-DRAGON-Registry
por: Wańha, Wojciech, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_dh361n2bf6rijcj1c5vubrompl